Author

Roberto Cioeta

Observed name: R Cioeta

Institution: Aboca (Italy)

Observed institution: Aboca (Italy)

ORCID: 0009-0006-5985-8871

Observed ORCID: 0009-0006-5985-8871

OpenAlex ID: A5068019132

A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices

2022 · Roberto Cioeta, Andrea Cossu, et al. · Frontiers in Drug Safety and Regulation · 13

Effectiveness and tolerability of Poliprotect, a natural mucosal protective agent for gastroesophageal reflux disease and dyspepsia: Surveys from patients, physicians, and pharmacists

2022 · Roberto Cioeta, Paola Muti, et al. · Frontiers in Drug Safety and Regulation · 12

A Substance-Based Medical Device for Managing Hemorrhoidal Disease: Output from a Cross-Sectional Survey

2025 · Roberto Cioeta, Paola Muti, et al. · Journal of Clinical Medicine · 1

Actitan: A Natural Complex for Managing Diarrhea—Insights from Cross-Sectional Survey Research Involving Patients, Pharmacists and Physicians

2024 · Roberto Cioeta, Paola Muti, et al. · Gastrointestinal Disorders · 1

Real-World Evidence on the Safe and Effective Use of a Medical Device Made of Natural Substances for the Treatment of Irritable Bowel Syndrome

2026 · Valeria Idone, Maria Chiara Moretti, et al. · Gastroenterology Insights

From Altered Metabolic and Anthropometric Parameters to Metabolic Syndrome: A Cross-Sectional Survey on the Effectiveness and Safety of Neo-Policaptil® Gel Retard

2025 · Elena Gabriele, Roberto Cioeta, et al. · Healthcare

MT6 Real World Clinical Data on the Use of a Natural Molecular Complex for the Treatment of Irritable Bowel Syndrome in Specialist Daily Practice

2022 · R Cioeta, R Cipelli, et al. · Value in Health

Works count: 7

Citation count: 27

H-index: 2

I10-index: 2